RxSight (RXST) Shareholder's Equity (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 52.06 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 22.98 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 49.20 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 26.10 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.96 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.67 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.20 Bn |
| 10 | RxSight | 215.82 Mn | -2.06 Mn | 23.50 Mn | 267.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 267.30 Mn |
| Dec 31, 2025 | 275.68 Mn |
| Sep 30, 2025 | 275.97 Mn |
| Jun 30, 2025 | 278.01 Mn |
| Mar 31, 2025 | 279.32 Mn |
| Dec 31, 2024 | 281.24 Mn |
| Sep 30, 2024 | 277.26 Mn |
| Jun 30, 2024 | 275.21 Mn |
| Mar 31, 2024 | 163.93 Mn |
| Dec 31, 2023 | 160.36 Mn |
| Sep 30, 2023 | 161.48 Mn |
| Jun 30, 2023 | 157.19 Mn |
| Mar 31, 2023 | 145.01 Mn |
| Dec 31, 2022 | 89.90 Mn |
| Sep 30, 2022 | 95.96 Mn |
| Jun 30, 2022 | 109.99 Mn |
| Mar 31, 2022 | 123.16 Mn |
| Dec 31, 2021 | 138.24 Mn |
| Sep 30, 2021 | 150.89 Mn |
| Jun 30, 2021 | -313.40 Mn |
| Mar 31, 2021 | -301.90 Mn |
| Dec 31, 2020 | -430.59 Mn |
| Sep 30, 2020 | -445.86 Mn |
| Jun 30, 2020 | -464.33 Mn |